APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor XI

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Coagulation Factor XI Market Analysis and Forecast 2026-2032

Report ID 173979050219 December 2025190 pages

Choose your research edition.

Industry ResearchCoagulation Factor XI Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor XI Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Coagulation Factor XI Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor XI Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor XI Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Coagulation Factor XI market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Coagulation Factor XI is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Coagulation Factor XI is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Coagulation Factor XI is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Coagulation Factor XI is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Coagulation Factor XI include Bristol-Myers Squibb Company, Cambryn Biologics LLC, eXithera Pharmaceuticals, Inc, Ionis Pharmaceuticals, Inc., LegoChem Biosciences, Inc and Bayer AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Coagulation Factor XI, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Coagulation Factor XI, also provides the revenue of main regions and countries. Of the upcoming market potential for Coagulation Factor XI, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Coagulation Factor XI revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Coagulation Factor XI market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Coagulation Factor XI revenue, projected growth trends, production technology, application and end-user industry.

Coagulation Factor XI Segment by Company

Bristol-Myers Squibb Company

Cambryn Biologics LLC

eXithera Pharmaceuticals, Inc

Ionis Pharmaceuticals, Inc.

LegoChem Biosciences, Inc

Bayer AG

Coagulation Factor XI Segment by Type

MR-1007

IONIS-FXIRx

EP-7041

BMS-262084

AB-022

Others

Coagulation Factor XI Segment by Application

Thrombosis

Acute Ischemic Stroke

Bleeding and Clotting Disorders

Others

Coagulation Factor XI Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor XI market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor XI and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor XI.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Coagulation Factor XI in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Coagulation Factor XI company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Coagulation Factor XI revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Coagulation Factor XI Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. MR-1007 Major Player Table 3. IONIS-FXIRx Major Player Table 4. EP-7041 Major Player Table 5. BMS-262084 Major Player Table 6. AB-022 Major Player Table 7. Others Major Player Table 8. Global Coagulation Factor XI Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Thrombosis Major Player Table 10. Acute Ischemic Stroke Major Player Table 11. Bleeding and Clotting Disorders Major Player Table 12. Others Major Player Table 13. Coagulation Factor XI Industry Trends Table 14. Coagulation Factor XI Industry Drivers Table 15. Coagulation Factor XI Industry Opportunities and Challenges Table 16. Coagulation Factor XI Industry Restraints Table 17. Global Coagulation Factor XI Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Coagulation Factor XI Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Coagulation Factor XI Market Share by Region (2021-2026) Table 20. Global Coagulation Factor XI Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Coagulation Factor XI Market Share by Region (2027-2032) Table 22. Global Coagulation Factor XI Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Coagulation Factor XI Revenue Market Share by Players (2021-2026) Table 24. Global Coagulation Factor XI Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Coagulation Factor XI Key Players Headquarters & Area Served Table 26. Global Coagulation Factor XI Players, Product Type & Application Table 27. Global Coagulation Factor XI Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Coagulation Factor XI by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Coagulation Factor XI Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Coagulation Factor XI Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Coagulation Factor XI Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Coagulation Factor XI Revenue Market Share by Type (2021-2026) Table 34. Global Coagulation Factor XI Revenue Market Share by Type (2027-2032) Table 35. Global Coagulation Factor XI Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Coagulation Factor XI Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Coagulation Factor XI Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Coagulation Factor XI Revenue Market Share by Application (2021-2026) Table 39. Global Coagulation Factor XI Revenue Market Share by Application (2027-2032) Table 40. Bristol-Myers Squibb Company Company Information Table 41. Bristol-Myers Squibb Company Business Overview Table 42. Bristol-Myers Squibb Company Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Bristol-Myers Squibb Company Coagulation Factor XI Product Portfolio Table 44. Bristol-Myers Squibb Company Recent Development Table 45. Cambryn Biologics LLC Company Information Table 46. Cambryn Biologics LLC Business Overview Table 47. Cambryn Biologics LLC Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Cambryn Biologics LLC Coagulation Factor XI Product Portfolio Table 49. Cambryn Biologics LLC Recent Development Table 50. eXithera Pharmaceuticals, Inc Company Information Table 51. eXithera Pharmaceuticals, Inc Business Overview Table 52. eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. eXithera Pharmaceuticals, Inc Coagulation Factor XI Product Portfolio Table 54. eXithera Pharmaceuticals, Inc Recent Development Table 55. Ionis Pharmaceuticals, Inc. Company Information Table 56. Ionis Pharmaceuticals, Inc. Business Overview Table 57. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product Portfolio Table 59. Ionis Pharmaceuticals, Inc. Recent Development Table 60. LegoChem Biosciences, Inc Company Information Table 61. LegoChem Biosciences, Inc Business Overview Table 62. LegoChem Biosciences, Inc Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. LegoChem Biosciences, Inc Coagulation Factor XI Product Portfolio Table 64. LegoChem Biosciences, Inc Recent Development Table 65. Bayer AG Company Information Table 66. Bayer AG Business Overview Table 67. Bayer AG Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Bayer AG Coagulation Factor XI Product Portfolio Table 69. Bayer AG Recent Development Table 70. North America Coagulation Factor XI Revenue by Type (2021-2026) & (US$ Million) Table 71. North America Coagulation Factor XI Revenue by Type (2027-2032) & (US$ Million) Table 72. North America Coagulation Factor XI Revenue by Application (2021-2026) & (US$ Million) Table 73. North America Coagulation Factor XI Revenue by Application (2027-2032) & (US$ Million) Table 74. North America Coagulation Factor XI Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Coagulation Factor XI Revenue by Country (2021-2026) & (US$ Million) Table 76. North America Coagulation Factor XI Revenue by Country (US$ Million) & (2027-2032) Table 77. Europe Coagulation Factor XI Revenue by Type (2021-2026) & (US$ Million) Table 78. Europe Coagulation Factor XI Revenue by Type (2027-2032) & (US$ Million) Table 79. Europe Coagulation Factor XI Revenue by Application (2021-2026) & (US$ Million) Table 80. Europe Coagulation Factor XI Revenue by Application (2027-2032) & (US$ Million) Table 81. Europe Coagulation Factor XI Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Europe Coagulation Factor XI Revenue by Country (2021-2026) & (US$ Million) Table 83. Europe Coagulation Factor XI Revenue by Country (US$ Million) & (2027-2032) Table 84. China Coagulation Factor XI Revenue by Type (2021-2026) & (US$ Million) Table 85. China Coagulation Factor XI Revenue by Type (2027-2032) & (US$ Million) Table 86. China Coagulation Factor XI Revenue by Application (2021-2026) & (US$ Million) Table 87. China Coagulation Factor XI Revenue by Application (2027-2032) & (US$ Million) Table 88. Asia Coagulation Factor XI Revenue by Type (2021-2026) & (US$ Million) Table 89. Asia Coagulation Factor XI Revenue by Type (2027-2032) & (US$ Million) Table 90. Asia Coagulation Factor XI Revenue by Application (2021-2026) & (US$ Million) Table 91. Asia Coagulation Factor XI Revenue by Application (2027-2032) & (US$ Million) Table 92. Asia Coagulation Factor XI Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Asia Coagulation Factor XI Revenue by Region (US$ Million) & (2021-2026) Table 94. Asia Coagulation Factor XI Revenue by Region (US$ Million) & (2027-2032) Table 95. SAMEA Coagulation Factor XI Revenue by Type (2021-2026) & (US$ Million) Table 96. SAMEA Coagulation Factor XI Revenue by Type (2027-2032) & (US$ Million) Table 97. SAMEA Coagulation Factor XI Revenue by Application (2021-2026) & (US$ Million) Table 98. SAMEA Coagulation Factor XI Revenue by Application (2027-2032) & (US$ Million) Table 99. SAMEA Coagulation Factor XI Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. SAMEA Coagulation Factor XI Revenue by Country (2021-2026) & (US$ Million) Table 101. SAMEA Coagulation Factor XI Revenue by Country (US$ Million) & (2027-2032) Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Coagulation Factor XI Image Figure 2. Global Coagulation Factor XI Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coagulation Factor XI Market Size Share 2021 VS 2025 VS 2032 Figure 4. MR-1007 Image Figure 5. IONIS-FXIRx Image Figure 6. EP-7041 Image Figure 7. BMS-262084 Image Figure 8. AB-022 Image Figure 9. Others Image Figure 10. Global Coagulation Factor XI Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Coagulation Factor XI Market Size Share 2021 VS 2025 VS 2032 Figure 12. Thrombosis Image Figure 13. Acute Ischemic Stroke Image Figure 14. Bleeding and Clotting Disorders Image Figure 15. Others Image Figure 16. Global Coagulation Factor XI Market Size (US$ Million) & (2021-2032) Figure 17. Global Coagulation Factor XI Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Coagulation Factor XI Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Coagulation Factor XI Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Coagulation Factor XI Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Coagulation Factor XI Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Coagulation Factor XI Revenue Market Share by Type (2021-2032) Figure 24. Global Coagulation Factor XI Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Coagulation Factor XI Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Coagulation Factor XI Revenue Market Share by Application (2021-2032) Figure 27. North America Coagulation Factor XI Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Coagulation Factor XI Revenue Share by Type (2021-2032) Figure 29. North America Coagulation Factor XI Revenue Share by Application (2021-2032) Figure 30. North America Coagulation Factor XI Revenue Share by Country (2021-2032) Figure 31. United States Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Coagulation Factor XI Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Coagulation Factor XI Revenue Share by Type (2021-2032) Figure 36. Europe Coagulation Factor XI Revenue Share by Application (2021-2032) Figure 37. Europe Coagulation Factor XI Revenue Share by Country (2021-2032) Figure 38. Germany Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Coagulation Factor XI Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Coagulation Factor XI Revenue Share by Type (2021-2032) Figure 48. China Coagulation Factor XI Revenue Share by Application (2021-2032) Figure 49. Asia Coagulation Factor XI Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Coagulation Factor XI Revenue Share by Type (2021-2032) Figure 51. Asia Coagulation Factor XI Revenue Share by Application (2021-2032) Figure 52. Asia Coagulation Factor XI Revenue Share by Region (2021-2032) Figure 53. Japan Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Coagulation Factor XI Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Coagulation Factor XI Revenue Share by Type (2021-2032) Figure 61. SAMEA Coagulation Factor XI Revenue Share by Application (2021-2032) Figure 62. SAMEA Coagulation Factor XI Revenue Share by Country (2021-2032) Figure 63. Brazil Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Coagulation Factor XI Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • MR-1007
  • IONIS-FXIRx
  • EP-7041
  • BMS-262084
  • AB-022
  • Others
Applications
  • Thrombosis
  • Acute Ischemic Stroke
  • Bleeding and Clotting Disorders
  • Others
Companies covered
  • Bristol-Myers Squibb Company
  • Cambryn Biologics LLC
  • eXithera Pharmaceuticals, Inc
  • Ionis Pharmaceuticals, Inc.
  • LegoChem Biosciences, Inc
  • Bayer AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Coagulation Factor XI Market by Type
  3. 1.2.1 Global Coagulation Factor XI Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 MR-1007
  5. 1.2.3 IONIS-FXIRx
  6. 1.2.4 EP-7041
  7. 1.2.5 BMS-262084
  8. 1.2.6 AB-022
  9. 1.2.7 Others
  10. 1.3 Coagulation Factor XI Market by Application
  11. 1.3.1 Global Coagulation Factor XI Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Thrombosis
  13. 1.3.3 Acute Ischemic Stroke
  14. 1.3.4 Bleeding and Clotting Disorders
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Coagulation Factor XI Market Dynamics
  1. 2.1 Coagulation Factor XI Industry Trends
  2. 2.2 Coagulation Factor XI Industry Drivers
  3. 2.3 Coagulation Factor XI Industry Opportunities and Challenges
  4. 2.4 Coagulation Factor XI Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Coagulation Factor XI Market Perspective (2021-2032)
  2. 3.2 Global Coagulation Factor XI Growth Trends by Region
  3. 3.2.1 Global Coagulation Factor XI Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Coagulation Factor XI Market Size by Region (2021-2026)
  5. 3.2.3 Global Coagulation Factor XI Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Coagulation Factor XI Revenue by Players
  2. 4.1.1 Global Coagulation Factor XI Revenue by Players (2021-2026)
  3. 4.1.2 Global Coagulation Factor XI Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Coagulation Factor XI Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Coagulation Factor XI Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Coagulation Factor XI Key Players Headquarters & Area Served
  7. 4.4 Global Coagulation Factor XI Players, Product Type & Application
  8. 4.5 Global Coagulation Factor XI Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Coagulation Factor XI Market CR5 and HHI
  11. 4.6.3 2025 Coagulation Factor XI Tier 1, Tier 2, and Tier 3
5 Coagulation Factor XI Market Size by Type
  1. 5.1 Global Coagulation Factor XI Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Coagulation Factor XI Revenue by Type (2021-2032)
  3. 5.3 Global Coagulation Factor XI Revenue Market Share by Type (2021-2032)
6 Coagulation Factor XI Market Size by Application
  1. 6.1 Global Coagulation Factor XI Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Coagulation Factor XI Revenue by Application (2021-2032)
  3. 6.3 Global Coagulation Factor XI Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Bristol-Myers Squibb Company
  2. 7.1.1 Bristol-Myers Squibb Company Company Information
  3. 7.1.2 Bristol-Myers Squibb Company Business Overview
  4. 7.1.3 Bristol-Myers Squibb Company Coagulation Factor XI Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Bristol-Myers Squibb Company Coagulation Factor XI Product Portfolio
  6. 7.1.5 Bristol-Myers Squibb Company Recent Developments
  7. 7.2 Cambryn Biologics LLC
  8. 7.2.1 Cambryn Biologics LLC Company Information
  9. 7.2.2 Cambryn Biologics LLC Business Overview
  10. 7.2.3 Cambryn Biologics LLC Coagulation Factor XI Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Cambryn Biologics LLC Coagulation Factor XI Product Portfolio
  12. 7.2.5 Cambryn Biologics LLC Recent Developments
  13. 7.3 eXithera Pharmaceuticals, Inc
  14. 7.3.1 eXithera Pharmaceuticals, Inc Company Information
  15. 7.3.2 eXithera Pharmaceuticals, Inc Business Overview
  16. 7.3.3 eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue and Gross Margin (2021-2026)
  17. 7.3.4 eXithera Pharmaceuticals, Inc Coagulation Factor XI Product Portfolio
  18. 7.3.5 eXithera Pharmaceuticals, Inc Recent Developments
  19. 7.4 Ionis Pharmaceuticals, Inc.
  20. 7.4.1 Ionis Pharmaceuticals, Inc. Company Information
  21. 7.4.2 Ionis Pharmaceuticals, Inc. Business Overview
  22. 7.4.3 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product Portfolio
  24. 7.4.5 Ionis Pharmaceuticals, Inc. Recent Developments
  25. 7.5 LegoChem Biosciences, Inc
  26. 7.5.1 LegoChem Biosciences, Inc Company Information
  27. 7.5.2 LegoChem Biosciences, Inc Business Overview
  28. 7.5.3 LegoChem Biosciences, Inc Coagulation Factor XI Revenue and Gross Margin (2021-2026)
  29. 7.5.4 LegoChem Biosciences, Inc Coagulation Factor XI Product Portfolio
  30. 7.5.5 LegoChem Biosciences, Inc Recent Developments
  31. 7.6 Bayer AG
  32. 7.6.1 Bayer AG Company Information
  33. 7.6.2 Bayer AG Business Overview
  34. 7.6.3 Bayer AG Coagulation Factor XI Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bayer AG Coagulation Factor XI Product Portfolio
  36. 7.6.5 Bayer AG Recent Developments
8 North America
  1. 8.1 North America Coagulation Factor XI Revenue (2021-2032)
  2. 8.2 North America Coagulation Factor XI Revenue by Type (2021-2032)
  3. 8.2.1 North America Coagulation Factor XI Revenue by Type (2021-2026)
  4. 8.2.2 North America Coagulation Factor XI Revenue by Type (2027-2032)
  5. 8.3 North America Coagulation Factor XI Revenue Share by Type (2021-2032)
  6. 8.4 North America Coagulation Factor XI Revenue by Application (2021-2032)
  7. 8.4.1 North America Coagulation Factor XI Revenue by Application (2021-2026)
  8. 8.4.2 North America Coagulation Factor XI Revenue by Application (2027-2032)
  9. 8.5 North America Coagulation Factor XI Revenue Share by Application (2021-2032)
  10. 8.6 North America Coagulation Factor XI Revenue by Country
  11. 8.6.1 North America Coagulation Factor XI Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Coagulation Factor XI Revenue by Country (2021-2026)
  13. 8.6.3 North America Coagulation Factor XI Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Coagulation Factor XI Revenue (2021-2032)
  2. 9.2 Europe Coagulation Factor XI Revenue by Type (2021-2032)
  3. 9.2.1 Europe Coagulation Factor XI Revenue by Type (2021-2026)
  4. 9.2.2 Europe Coagulation Factor XI Revenue by Type (2027-2032)
  5. 9.3 Europe Coagulation Factor XI Revenue Share by Type (2021-2032)
  6. 9.4 Europe Coagulation Factor XI Revenue by Application (2021-2032)
  7. 9.4.1 Europe Coagulation Factor XI Revenue by Application (2021-2026)
  8. 9.4.2 Europe Coagulation Factor XI Revenue by Application (2027-2032)
  9. 9.5 Europe Coagulation Factor XI Revenue Share by Application (2021-2032)
  10. 9.6 Europe Coagulation Factor XI Revenue by Country
  11. 9.6.1 Europe Coagulation Factor XI Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Coagulation Factor XI Revenue by Country (2021-2026)
  13. 9.6.3 Europe Coagulation Factor XI Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Coagulation Factor XI Revenue (2021-2032)
  2. 10.2 China Coagulation Factor XI Revenue by Type (2021-2032)
  3. 10.2.1 China Coagulation Factor XI Revenue by Type (2021-2026)
  4. 10.2.2 China Coagulation Factor XI Revenue by Type (2027-2032)
  5. 10.3 China Coagulation Factor XI Revenue Share by Type (2021-2032)
  6. 10.4 China Coagulation Factor XI Revenue by Application (2021-2032)
  7. 10.4.1 China Coagulation Factor XI Revenue by Application (2021-2026)
  8. 10.4.2 China Coagulation Factor XI Revenue by Application (2027-2032)
  9. 10.5 China Coagulation Factor XI Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Coagulation Factor XI Revenue (2021-2032)
  2. 11.2 Asia Coagulation Factor XI Revenue by Type (2021-2032)
  3. 11.2.1 Asia Coagulation Factor XI Revenue by Type (2021-2026)
  4. 11.2.2 Asia Coagulation Factor XI Revenue by Type (2027-2032)
  5. 11.3 Asia Coagulation Factor XI Revenue Share by Type (2021-2032)
  6. 11.4 Asia Coagulation Factor XI Revenue by Application (2021-2032)
  7. 11.4.1 Asia Coagulation Factor XI Revenue by Application (2021-2026)
  8. 11.4.2 Asia Coagulation Factor XI Revenue by Application (2027-2032)
  9. 11.5 Asia Coagulation Factor XI Revenue Share by Application (2021-2032)
  10. 11.6 Asia Coagulation Factor XI Revenue by Country
  11. 11.6.1 Asia Coagulation Factor XI Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Coagulation Factor XI Revenue by Country (2021-2026)
  13. 11.6.3 Asia Coagulation Factor XI Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Coagulation Factor XI Revenue (2021-2032)
  2. 12.2 SAMEA Coagulation Factor XI Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Coagulation Factor XI Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Coagulation Factor XI Revenue by Type (2027-2032)
  5. 12.3 SAMEA Coagulation Factor XI Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Coagulation Factor XI Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Coagulation Factor XI Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Coagulation Factor XI Revenue by Application (2027-2032)
  9. 12.5 SAMEA Coagulation Factor XI Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Coagulation Factor XI Revenue by Country
  11. 12.6.1 SAMEA Coagulation Factor XI Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Coagulation Factor XI Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Coagulation Factor XI Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst